|
Real-time Estimate
Tradegate
12:03:21 13/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 132.53 EUR | 0.00% |
|
-2.58% | +20.55% |
| 09:14pm | PeptiDream Hits Milestone as Novartis Begins Phase 1 Trial for Cancer Therapy | MT |
| 12/08 | Global drugmakers invest billions to boost US presence | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.59% | +3.19% | +2.14% | +21.95% | +12.33% | +88.79% | +124.38% | +358.17% | +1,404.80% | 1,083B | |
| -0.44% | -0.00% | -0.07% | +14.86% | +24.46% | +49.08% | +48.51% | +47.02% | +109.04% | 626B | |
| -0.64% | +0.95% | +0.22% | +19.58% | +8.78% | +25.13% | +63.23% | +114.93% | +269.92% | 442B | |
| -1.29% | -0.47% | +9.77% | +12.91% | +10.60% | +47.32% | +37.06% | -1.06% | +46.08% | 363B | |
| -1.33% | -0.40% | -0.50% | +6.95% | +13.10% | +28.82% | +36.34% | +44.58% | +54.85% | 295B | |
| -0.91% | -2.79% | -7.21% | -14.89% | -15.15% | +5.54% | +5.28% | +40.99% | +129.20% | 248B | |
| +0.16% | +0.96% | +14.23% | +22.43% | +25.79% | +44.48% | +57.77% | +80.46% | +137.97% | 224B | |
| -2.73% | +1.41% | -8.00% | +0.66% | -8.24% | -6.88% | -51.81% | -7.27% | +94.43% | 210B | |
| +0.41% | +2.94% | +3.22% | +0.51% | +10.50% | +13.01% | +69.86% | +91.35% | +70.26% | 168B | |
| -1.07% | +2.15% | +7.70% | +1.91% | +5.88% | +6.96% | -26.91% | -44.19% | -24.63% | 152B | |
| +0.22% | +8.63% | +9.67% | +17.49% | +16.17% | +35.82% | +50.75% | +170.36% | +418.74% | 134B | |
| +0.22% | -0.21% | +7.01% | +12.49% | +17.72% | +36.41% | +3.05% | -5.16% | +4.73% | 130B | |
| +0.23% | +1.42% | -2.00% | +3.00% | -8.66% | -7.46% | -22.59% | -13.48% | +5.38% | 104B | |
| -1.86% | -3.05% | -4.94% | -1.82% | +1.78% | +32.22% | +33.98% | +0.79% | -12.15% | 103B | |
| +1.01% | +7.42% | -0.64% | -7.83% | -12.85% | +16.26% | +68.80% | +75.48% | +485.65% | 73.47B | |
| -0.36% | +5.56% | +4.59% | +7.62% | +15.04% | +28.01% | +25.07% | +52.55% | +15.68% | 55.96B | |
| -0.54% | -1.06% | -2.44% | +26.69% | +31.59% | +87.60% | -7.61% | +1.53% | -50.36% | 55.49B | |
| +1.46% | +2.90% | -1.40% | +2.71% | -7.72% | -9.99% | +40.23% | -3.37% | +232.32% | 53.72B | |
| -1.38% | -1.70% | -1.51% | +7.31% | -4.08% | +1.27% | +6.53% | - | - | 43.48B | |
| Average | -0.49% | +3.02% | +1.57% | +8.13% | +7.21% | +27.49% | +29.57% | +55.76% | +188.44% | 240.21B | |
| Weighted average by Cap. | -0.67% | +4.14% | +1.89% | +12.31% | +10.52% | +42.95% | +53.70% | +120.67% | +428.07% |
- Stock Market
- Stocks
- NOVN Stock
- NOVN Stock
- Sector Novartis
Select your edition
All financial news and data tailored to specific country editions
